Xinjiang Haoyuan Gas Co. Ltd. logo

Xinjiang Haoyuan Gas Co. Ltd. (002700)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
6. 08
+0.02
+0.33%
¥
2.44B Market Cap
- P/E Ratio
1,800% Div Yield
7.49M Volume
1,193.51 Eps
¥ 6.06
Previous Close
Add Transaction
Day Range
5.98 6.17
Year Range
4.86 9.72
Want to track 002700 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002700 closed today higher at ¥6.08, an increase of 0.33% from yesterday's close, completing a monthly decrease of -1.9355% or -¥0.12. Over the past 12 months, 002700 stock lost -9.389%.
002700 pays dividends to its shareholders, with the most recent payment made on Jul 17, 2026. The next estimated payment will be in In 11 months on Jul 17, 2027 for a total of ¥0.025.
The last earnings report, released on Oct 30, 2024, exceeded the consensus estimates by 0.0735%. On average, the company has surpassed earnings expectations by 0.0662%, based on the last three reports.
Xinjiang Haoyuan Gas Co. Ltd. has completed 3 stock splits, with the recent split occurring on Apr 30, 2015.
The company's stock is traded on one exchange.

002700 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Xinjiang Haoyuan Gas Co. Ltd. (002700) FAQ

What is the stock price today?

The current price is ¥6.08.

On which exchange is it traded?

Xinjiang Haoyuan Gas Co. Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002700.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1,800%.

What is its market cap?

As of today, the market cap is 2.44B.

Has Xinjiang Haoyuan Gas Co. Ltd. ever had a stock split?

Xinjiang Haoyuan Gas Co. Ltd. had 3 splits and the recent split was on Apr 30, 2015.

Xinjiang Haoyuan Gas Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Wook-Je Cho CEO
XSHE Exchange
CNE100001NX8 ISIN
KR Country
2,087 Employees
- Last Dividend
30 Apr 2015 Last Split
21 Sep 2012 IPO Date

Overview

Yuhan Corporation, established in 1926, stands as a distinguished entity in the pharmaceutical sector, both in South Korea and on a global scale. Its corporate headquarters are situated in Seoul, South Korea, a testament to its rich heritage and foundational roots within the country's pharmaceutical industry. The organization is deeply involved in a myriad of activities ranging from the research and development (R&D) to the manufacturing and international distribution of pharmaceutical products and intermediates. This extensive involvement has earmarked Yuhan Corporation as a multifaceted company that not only explores the depths of pharmaceutical innovations but also ensures the widespread availability of high-quality medical solutions across the world. Yuhan's commitment to healthcare excellence is reflected in their comprehensive array of product offerings, which cater to various medical needs and conditions, bolstering their reputation as a leading pharmaceutical company.

Products and Services

Yuhan Corporation offers a vast portfolio of products and services designed to meet the healthcare needs of patients worldwide. Below are key highlights from their offerings:

  • Active Pharmaceutical Ingredients (APIs): Including antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds. These APIs form the cornerstone of numerous medications, offering diverse therapeutic benefits.
  • Revanex: Specifically formulated as an acid pump antagonist, Revanex is prescribed for the treatment of peptic ulcers and gastritis-related mucosal injuries, showcasing Yuhan's commitment to addressing gastrointestinal disorders.
  • ETC Products: The company's ETC (Ethical Pharmaceuticals) product line spans across various therapeutic categories, including cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, neuro systems, anti-infective, anti-cancer, hormone therapies, and more. Each category is filled with innovative solutions tailored to patient needs.
  • OTC Products: Yuhan's over-the-counter offerings feature vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, and dermatology and analgesics drugs, ensuring accessible healthcare solutions without the need for a prescription.
  • Veterinary Drugs: The company extends its expertise to the veterinary field, providing a range of drugs and feeds aimed at improving the health and well-being of animals, demonstrating Yuhan's holistic approach to healthcare.
  • Household and Healthcare Products: Beyond pharmaceuticals, Yuhan Corporation manufactures and markets a variety of household and healthcare products, articulating its diversification into everyday health and wellness solutions.
  • Dental Care Products: Catering to oral health, the company offers a selection of dental care products, advocating for comprehensive healthcare that includes oral hygiene.
  • Contract Manufacturing Services: Yuhan Corporation provides contract manufacturing services, leveraging its extensive R&D and manufacturing capabilities to offer customized and high-quality manufacturing solutions to partners worldwide.

Contact Information

Address: 74, Noryangjin-ro, Seoul, South Korea
Phone: 82 2 828 0181